Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met

T Damghani, F Moosavi, M Khoshneviszadeh… - Scientific Reports, 2021 - nature.com
Aberrant activation of c-Met signalling plays a prominent role in cancer development and
progression. A series of 12 imidazo [1, 2-α] pyridine derivatives bearing 1, 2, 3-triazole …

Molecular insights of metastasis and cancer progression derived using 3D cancer spheroid co-culture in vitro platform

U Modi, P Makwana, R Vasita - Critical Reviews in Oncology/Hematology, 2021 - Elsevier
The multistep metastasis process is carried out by the combinatorial effect of the stromal
cells and the cancerous cells and plays vital role in the cancer progression. The …

Biodegradable ultrasmall-in-nano architectures loaded with cisplatin prodrug in combination with ionizing radiation induces DNA damage and apoptosis in pancreatic …

PP Che, AK Mapanao, A Gregori, ML Ermini… - Cancers, 2022 - mdpi.com
Simple Summary The occurrence of severe normal tissue side effects and acquired drug
resistance of the malignancy are the most important limitations that are associated with …

Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds

G Li Petri, B El Hassouni, R Sciarrillo, N Funel… - British journal of …, 2020 - nature.com
Background Expression of proton-coupled folate transporter (PCFT) is associated with
survival of mesothelioma patients treated with pemetrexed, and is reduced by hypoxia …

Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature

Y Wu, J Shang, Q Ruan, X Tan - Scientific Reports, 2023 - nature.com
Pancreatic cancer (PC) is known for its high degree of heterogeneity and exceptionally
adverse outcome. While disulfidptosis is the most recently identified form of cell death, the …

Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers

G Mantini, AM Vallés, TYS Le Large, M Capula… - Cellular oncology, 2020 - Springer
Purpose Despite extensive biological and clinical studies, including comprehensive
genomic and transcriptomic profiling efforts, pancreatic ductal adenocarcinoma (PDAC) …

Epithelial and mesenchymal features of pancreatic ductal adenocarcinoma cell lines in two-and three-dimensional cultures

Y Shichi, F Gomi, N Sasaki, K Nonaka, T Arai… - Journal of Personalized …, 2022 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer that is difficult to
diagnose early, and there is no cure other than surgery. PDAC is classified as an …

Novel quinazoline-1, 2, 3-triazole hybrids with anticancer and MET kinase targeting properties

M Mortazavi, M Eskandari, F Moosavi, T Damghani… - Scientific Reports, 2023 - nature.com
Oncogenic activation of receptor tyrosine kinases (RTKs) such as MET is associated with
cancer initiation and progression. We designed and synthesized a new series of quinazoline …

Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids

MM Abu-Serie - Nanomedicine, 2024 - Taylor & Francis
Background: Cancer stem cells'(CSCs) resistance to 5-fluorouracil (Fu), which is the main
obstacle in treating colon cancer (CC), can be overcome by ferroptosis. The latter, herein …

Chemotherapy assessment in advanced multicellular 3D models of pancreatic cancer: Unravelling the importance of spatiotemporal mimicry of the tumor …

P Gupta, C Bermejo‐Rodriguez, H Kocher… - Advanced …, 2024 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is a challenge for global health with very low
survival rate and high therapeutic resistance. Hence, advanced preclinical models for …